TCG Crossover GP II, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share (ADVM)

Filing Manager: TCG Crossover GP II, LLC
Reporting Manager: TCG Crossover GP II, LLC
Security: Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share
Symbol: ADVM
Shares outstanding: 21M shares
Disclosed Ownership: 1.87M shares
Ownership: 8.9%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 16:34:45 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
TCG Crossover GP II, LLC	8.9%	1.87M	1.87M	/s/ Craig Skaling	Authorized Signatory
TCG Crossover Fund II, L.P.	8.9%	1.87M	1.87M	/s/ Craig Skaling	Authorized Signatory
Chen Yu	8.9%	1.87M	1.87M	/s/ Craig Skaling	By POA as Attorney-in-Fact